RY 170.3 -0.8096% SHOP 145.34 -0.4452% TD 78.23 0.3206% ENB 59.82 -0.2168% BN 78.84 -0.5801% TRI 224.58 0.0445% CNQ 47.21 0.3614% CP 102.88 -0.1843% CNR 149.43 0.2348% BMO 131.48 0.0533% BNS 78.71 0.421% CSU 4503.0698 1.5097% CM 90.72 0.9683% MFC 45.03 -1.0547% ATD 77.2 -0.5026% NGT 60.11 -0.2489% TRP 68.79 -1.1638% SU 57.1 -0.1923% WCN 260.8 -0.401% L 177.26 1.1758%
Last update at 2024-11-20T21:00:00Z
Exploring Three TSX Stocks With Estimated Discounts Ranging From 14.1% To 42.8%
Wed 10 Jul 24, 12:08 PMTop 3 TSX Stocks Estimated To Be Below Market Value In July 2024
Mon 08 Jul 24, 12:03 PMExploring Three TSX Stocks With Intrinsic Value Discounts Ranging From 25.4% To 41.4%
Wed 03 Jul 24, 12:03 PMBoyd Group Services And Two More TSX Stocks Seemingly Priced Below Intrinsic Value Estimates
Tue 02 Jul 24, 12:07 PMExploring Undervalued TSX Stocks For June 2024
Fri 28 Jun 24, 12:08 PMGreen Thumb Industries And Two Other Stocks Estimated As Undervalued On TSX
Thu 27 Jun 24, 12:08 PMTop 3 TSX Stocks Estimated To Be Trading Below Value In June 2024
Wed 26 Jun 24, 12:05 PMGreen Thumb Industries Leads Three Value Picks On TSX That Investors Might Consider Undervalued
Tue 25 Jun 24, 12:03 PMJamieson Wellness Inc.'s (TSE:JWEL) Stock Is Going Strong: Have Financials A Role To Play?
Mon 15 Jan 24, 10:29 AMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 70.50M | 70.47M | 57.05M | 42.30M | 37.25M |
Minority interest | - | - | - | - | - |
Net income | 52.81M | 52.08M | 41.60M | 31.66M | 26.67M |
Selling general administrative | 115.15M | 86.41M | 81.18M | 74.28M | 66.29M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 198.34M | 162.44M | 144.76M | 129.73M | 115.42M |
Reconciled depreciation | 17.25M | 14.27M | 12.21M | 10.92M | 9.05M |
Ebit | 83.19M | 76.03M | 63.57M | 55.45M | 44.80M |
Ebitda | 100.44M | 90.30M | 75.76M | 61.92M | 53.84M |
Depreciation and amortization | 17.25M | 14.27M | 12.19M | 6.47M | 9.05M |
Non operating income net other | - | - | - | - | - |
Operating income | 83.19M | 76.03M | 63.57M | 55.45M | 50.09M |
Other operating expenses | 464.18M | 375.00M | 340.09M | 289.53M | 270.65M |
Interest expense | 12.42M | 5.66M | 6.04M | 8.29M | 7.55M |
Tax provision | 17.70M | 18.38M | 15.45M | 10.65M | 10.58M |
Interest income | 12.69M | 5.57M | 6.50M | 9.78M | 9.61M |
Net interest income | -12.41700M | -5.65700M | -6.04200M | -10.81400M | -9.00000M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 17.70M | 18.38M | 15.45M | 10.65M | 10.58M |
Total revenue | 547.37M | 451.03M | 403.66M | 344.98M | 319.78M |
Total operating expenses | 115.15M | 86.41M | 81.18M | 74.28M | 66.29M |
Cost of revenue | 349.03M | 288.59M | 258.90M | 215.25M | 204.36M |
Total other income expense net | -12.68600M | -5.56500M | -6.52400M | -13.14500M | -12.83900M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 52.81M | 52.08M | 41.60M | 31.66M | 26.67M |
Net income applicable to common shares | 52.81M | 52.08M | 41.60M | 31.66M | 26.67M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 1143.57M | 1107.26M | 652.48M | 609.34M | 561.77M |
Intangible assets | 366.52M | 367.20M | 192.68M | 196.16M | 198.19M |
Earning assets | - | - | - | - | - |
Other current assets | 9.04M | 10.88M | 7.18M | 2.39M | 1.89M |
Total liab | 662.38M | 675.67M | 310.45M | 316.94M | 302.61M |
Total stockholder equity | 438.93M | 431.59M | 342.02M | 292.40M | 259.17M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 7.55M | 26.04M | 25.70M | 32.48M | 17.30M |
Common stock | 312.59M | 307.20M | 268.21M | 255.79M | 243.22M |
Capital stock | 312.59M | 307.20M | 268.21M | 255.79M | 243.22M |
Retained earnings | 80.65M | 85.48M | 59.00M | 29.02M | 6.06M |
Other liab | - | 95.63M | 56.84M | 55.02M | 55.03M |
Good will | 274.41M | 272.92M | 122.97M | 122.97M | 122.97M |
Other assets | - | 3.03M | 2.70M | 2.26M | 2.27M |
Cash | 36.86M | 26.24M | 6.78M | 1.17M | 0.20M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 145.33M | 154.81M | 83.62M | 91.01M | 73.34M |
Current deferred revenue | 53.78M | - | - | - | - |
Net debt | 426.12M | 373.76M | 142.35M | 147.89M | 164.57M |
Short term debt | 7.55M | 0.00000M | 0.00000M | 14.62M | 0.00000M |
Short long term debt | - | - | - | - | - |
Short long term debt total | 462.99M | 400.00M | 149.12M | 149.06M | 164.77M |
Other stockholder equity | 33.79M | 17.11M | 14.79M | 12.99M | 10.73M |
Property plant equipment | - | 111.71M | 96.98M | 83.80M | 64.91M |
Total current assets | 392.86M | 352.40M | 237.15M | 204.15M | 173.43M |
Long term investments | - | - | - | - | - |
Net tangible assets | - | -208.53000M | 26.37M | -26.73100M | -61.99600M |
Short term investments | 3.29M | - | - | - | - |
Net receivables | 164.50M | 160.80M | 104.19M | 97.95M | 89.39M |
Long term debt | 325.00M | 400.00M | 149.12M | 149.06M | 164.77M |
Inventory | 182.46M | 154.49M | 119.01M | 102.64M | 81.95M |
Accounts payable | 76.46M | 128.77M | 57.92M | 58.53M | 56.04M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | 11.89M | 21.79M | 0.02M | -5.40200M | -0.84400M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | 255.79M | 243.22M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 2.88M | - | - | - | 388.34M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 750.71M | 754.86M | 415.33M | 405.19M | 388.34M |
Capital lease obligations | - | - | - | - | - |
Long term debt total | - | 461.93M | 170.00M | 170.91M | 174.24M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -256.53000M | -22.28400M | -13.16900M | -9.49800M | -11.53700M |
Change to liabilities | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
Total cashflows from investing activities | -256.53000M | -22.28400M | -13.16900M | -9.49800M | -11.53700M |
Net borrowings | 247.54M | -3.14000M | -18.07900M | -6.08300M | 1.25M |
Total cash from financing activities | 225.41M | -16.51200M | -26.45900M | -19.14500M | -8.65600M |
Change to operating activities | -27.01200M | -27.32600M | -20.20400M | -34.49900M | -5.17000M |
Net income | 52.81M | 52.08M | 41.60M | 31.66M | 26.67M |
Change in cash | 19.46M | 5.61M | 0.97M | -12.24700M | 7.61M |
Begin period cash flow | 6.78M | 1.17M | 0.20M | 12.45M | 4.83M |
End period cash flow | 26.24M | 6.78M | 1.17M | 0.20M | 12.45M |
Total cash from operating activities | 50.59M | 44.41M | 40.60M | 16.40M | 27.80M |
Issuance of capital stock | - | - | - | - | 0.00000M |
Depreciation | 17.25M | 14.27M | 12.21M | 10.92M | 9.05M |
Other cashflows from investing activities | -242.59700M | -0.78600M | -1.91800M | -0.47100M | -0.60200M |
Dividends paid | 26.32M | 22.11M | 18.64M | 14.69M | 12.94M |
Change to inventory | - | - | - | - | - |
Change to account receivables | - | - | - | - | - |
Sale purchase of stock | 4.19M | 8.73M | 10.26M | 1.62M | 3.03M |
Other cashflows from financing activities | 343.58M | 81.62M | 70.55M | 48.85M | 40.94M |
Change to netincome | 7.54M | 5.38M | 6.99M | 5.30M | -4.19700M |
Capital expenditures | 14.57M | 22.28M | 13.17M | 9.50M | 11.54M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | -27.01200M | -27.32600M | -20.20400M | -34.49900M | -5.17000M |
Stock based compensation | 4.76M | 5.48M | 4.57M | 3.88M | 3.07M |
Other non cash items | 1.12M | 0.38M | 0.48M | 3.33M | -6.00700M |
Free cash flow | 36.02M | 22.12M | 27.43M | 6.90M | 16.27M |
Sector: Consumer Defensive Industry: Packaged Foods
Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
JWEL Jamieson Wellness Inc |
0.38 1.08% | 35.63 | 39.30 | 17.45 | 2.10 | 3.36 | 2.51 | 18.26 |
SAP Saputo Inc |
-0.05 0.19% | 26.00 | 42.40 | 15.43 | 0.63 | 1.53 | 0.82 | 13.35 |
PBH Premium Brands Holdings Corporation |
-0.01 0.01% | 80.34 | 34.84 | 14.31 | 0.54 | 1.96 | 0.98 | 12.08 |
MFI Maple Leaf Foods Inc. |
-0.02 0.09% | 22.62 | 252.22 | 15.77 | 0.58 | 1.76 | 0.97 | 10.14 |
HLF High Liner Foods Incorporated |
-0.25 1.67% | 14.74 | 6.88 | 6.36 | 0.41 | 0.73 | 0.52 | 5.03 |
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. The company offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. It also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women, including hormone imbalances, nutrient deficiencies, and sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. The company offers its contract manufacturing services under the Nurticorp brand. It sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
TD Bank Tower, Toronto, ON, Canada, M5K 1E6
Name | Title | Year Born |
---|---|---|
Mr. Michael Pilato | Pres, CEO & Director | 1975 |
Mr. Christopher Snowden | CFO & Corp. Sec. | NA |
Ms. Regan Stewart | Chief Operations & People Officer | NA |
Mr. John Doherty | Chief Science & Innovation Officer | 1973 |
Mr. Don Bird | Exec. VP of USA & Global Strategic Partners | 1964 |
Ruth Winker | Corp. Communications Director | NA |
Mr. Eric Bentz | Sr. VP of Global Marketing & MD of China | NA |
Mr. Paul Galbraith | Sr. VP & MD of Canada | NA |
Mr. Joel Scales | Exec. VP of Jamieson Worldwide, Global Strategy & E-Commerce | NA |
Mr. Michael Pilato | President, CEO & Director | 1975 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.